| CYCU | PRESS-RELEASE | neutral | 1/10 | Cycurion announced it will host a conference call on November 16, 2026 to discuss its Q3 results. | Oct 22, 2026 |
| NSC | PRESS-RELEASE | bullish | 6/10 | Norfolk Southern reported Q3 2026 adjusted EPS of $3.62, a 4.3% beat vs consensus of $3.47, on record quarterly revenue | Oct 22, 2026 |
| STEP | PRESS-RELEASE | neutral | 1/10 | StepStone Group Inc announced it will report its fiscal Q2 2027 results on November 5, 2026. | Oct 22, 2026 |
| SCNX | PRESS-RELEASE | mixed | 5/10 | Scienture Holdings reported preliminary Q3 2026 revenue of ~$1.22M, up 256% sequentially from Q2's $344K, driven by Arbl | Oct 22, 2026 |
| CYRX | PRESS-RELEASE | neutral | 1/10 | Cryoport, Inc. announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| INVZ | PRESS-RELEASE | neutral | 1/10 | Innoviz Technologies announced it will host a conference call on November 11 to discuss its Q3 2026 results. | Oct 22, 2026 |
| CNR | PRESS-RELEASE | neutral | 1/10 | Core Natural Resources announced it will report its Q3 2026 results on November 5. | Oct 22, 2026 |
| GPGI | PRESS-RELEASE | neutral | 1/10 | GPGI, Inc. announced it will report its Q3 2026 results. | Oct 22, 2026 |
| YETI | PRESS-RELEASE | neutral | 1/10 | YETI Holdings, Inc. announced it will report its fiscal Q3 2026 results on November 12, 2026. | Oct 22, 2026 |
| LENZ | PRESS-RELEASE | neutral | 1/10 | LENZ Therapeutics, Inc. announced it will report its Q3 2026 results on October 29, 2026. | Oct 22, 2026 |
| KRT | PRESS-RELEASE | neutral | 1/10 | Karat Packaging Inc. announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| WHG | PRESS-RELEASE | neutral | 1/10 | Westwood Holdings Group Inc announced it will host a conference call on November 5, 2026 to discuss its Q3 2026 results. | Oct 22, 2026 |
| TEAD | PRESS-RELEASE | neutral | 1/10 | Teads Holding Co. announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| REPL | PRESS-RELEASE | neutral | 1/10 | Replimune, Inc. announced it will report its fiscal Q2 2027 results on October 28, 2026. | Oct 22, 2026 |
| COLL | PRESS-RELEASE | neutral | 1/10 | Collegium Pharmaceutical, Inc. announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| GSIT | PRESS-RELEASE | neutral | 1/10 | GSI Technology, Inc. announced it will report its fiscal Q2 2027 results on November 5, 2026. | Oct 22, 2026 |
| PLNT | PRESS-RELEASE | neutral | 1/10 | Planet Fitness, Inc. announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| KRYS | PRESS-RELEASE | neutral | 1/10 | Krystal Biotech, Inc. announced it will report its Q3 2026 results on November 2, 2026. | Oct 22, 2026 |
| OPRA | PRESS-RELEASE | neutral | 1/10 | Opera Limited announced it will report its Q3 2026 results on November 17, 2026. | Oct 22, 2026 |
| WSC | PRESS-RELEASE | neutral | 1/10 | WillScot announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| ASPN | PRESS-RELEASE | neutral | 1/10 | Aspen Aerogels, Inc. announced it will report its Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| CRS | PRESS-RELEASE | bullish | 6/10 | Carpenter Technology reported Q1 FY2027 EPS of $3.25, beating consensus of $3.03 by 7.2%, on revenue of $798.2M vs $830. | Oct 22, 2026 |
| MIRA | PRESS-RELEASE | bullish | 5/10 | MIRA Pharmaceuticals announced positive preclinical results for oral MIRA-55 in a 21-day chronic inflammatory pain model | Oct 22, 2026 |
| CLMB | PRESS-RELEASE | bullish | 5/10 | Climb Global Solutions acquired NeoVAD, a France-based value-added IT distributor, for approximately €16.0 million ($18. | Oct 22, 2026 |
| GCBC | PRESS-RELEASE | bullish | 6/10 | Greene County Bancorp reported record net income of $12.5M ($0.73 EPS) for Q1 FY2027, up 40.9% YoY from $8.9M ($0.52 EPS | Oct 22, 2026 |
| CASS | PRESS-RELEASE | neutral | 4/10 | Cass Information Systems reported Q3 2026 GAAP diluted EPS of $0.81, beating the $0.80 consensus by 1.25% (in-line by th | Oct 22, 2026 |
| SCYX | PRESS-RELEASE | bullish | 7/10 | Scynexis announced positive Phase 1 topline results for IV SCY-247, showing good tolerability and target exposures at 50 | Oct 22, 2026 |
| APYX | PRESS-RELEASE | neutral | 1/10 | Apyx Medical Corporation announced it will report its fiscal Q3 2026 results on November 5, 2026. | Oct 22, 2026 |
| OXLCO | PRESS-RELEASE | neutral | 4/10 | Oxford Lane Capital Corp. priced an additional 1,440,000 shares of its 8.25% Series 2031 Term Preferred Stock at $24.85 | Oct 22, 2026 |
| KELYA | PRESS-RELEASE | neutral | 1/10 | Kelly Services, Inc. announced it will host a conference call to discuss its Q3 2026 results. | Oct 22, 2026 |
